• Search Archives

  • Categories





  • We are one of a few medical consumer advocacy organizations in the U.S. that takes no funding from the pharmaceutical and device industries.




American Cancer Society

Posted by medconsumers on October 21, 2000

On October 21, 2009, the American Cancer Society was described in a front-page New York Times article as “quietly working on a message, to put on its Web site early next year, to emphasize that screening for breast and prostate cancer and certain other cancers can come with a real risk of overtreating many small cancers while missing cancers that are deadly.” We congratulate the ACS for planning to bring balance to its longstanding, overly optimistic early detection messages.

Otis W. Brawley, MD, medical director of the ACS, is the main force behind this plan, according to the New York Times article. Read our 2003 interview with Dr. Brawley regarding his views about informed consent and the PSA screening test for prostate cancer. And this 2000 inteview for PSA Rising magazine.

[Note: Three days after the New York Times article was published, Dr. Brawley canceled the plan in a letter to the editor of the Times, saying that the ACS has always provided balanced information about screening tests.]

Sorry, the comment form is closed at this time.

 
Follow

Get every new post delivered to your Inbox.

Join 52 other followers